Induction Immunosuppression in Kidney Transplant Recipients Older than 60 Years of Age: Safety and Efficacy of ATGAM®, OKT3® and Simulect®

Author： Michael Heifets   Muhammad I. Saeed   Mitten H. Parikh   Debra Sierka   Mysore S.A. Kumar  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.21, Iss.11, 2004-01, pp. : 747-756

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Options for Induction Immunosuppression in Liver Transplant Recipients

By Moser M.A.J.  

Drugs, Vol. 62, Iss. 7, 2002-01 ,pp. : 995-1011

Adis International

Access to resources Recommend Favorite

Long-term use of ciclosporin on kidney transplant recipients surviving more than 10 years

By Qin Yan   Fan Yu   Mu Xingyu   Zhang Fang   Shen Bing   Liu Yong   Guo Yifeng   Wang Yong   Qiu Jianxin  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 7, 2014-07 ,pp. : 558-560

Govi-Verlag

Access to resources Recommend Favorite

The Role of Immunosuppressive Medications in the Pathogenesis of Hypertension and Efficacy and Safety of Antihypertensive Agents in Kidney Transplant Recipients

By  

Current Medicinal Chemistry, Vol. 23, Iss. 19, 2016-07 ,pp. : 1941-1952

Bentham Science Publishers

Access to resources Recommend Favorite

Tolerogenic immunosuppression for organ transplant recipients

By  

Inpharma, Vol. 1, Iss. 1386, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Impact of Absorption Profiling on Efficacy and Safety of Cyclosporin Therapy in Transplant Recipients

By Belitsky P.  

Clinical Pharmacokinetics, Vol. 39, Iss. 2, 2000-08 ,pp. : 117-125

Adis International

Access to resources Recommend Favorite